BioVersys SAS: Clinical Trials

2 completed, 2 recruiting. 3 Phase 1, 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 1	3	Completed 2, Recruiting 1
Phase 3	1	Recruiting 1

Follow BioVersys SAS: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex BV100 (300 mg), Polymyxin B, Colistin - Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP)	Phase 3	Recruiting	BioVersys SAS	248	2026-03-27	2026-05-04
A Single Centre, Open-label, 2-period Fixed-sequence, Phase I Clinical Study to Evaluate the Effect of BV100 on the Pharmacokinetics of Polymyxin B in Healthy Volunteers BV100 (300 mg), Polymyxin B (50 mg) - Healthy Adult Participants	Phase 1	Recruiting	BioVersys SAS	16	2026-03-22	2026-05-12
Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Healthy Male Subjects BV100, Placebo - Healthy Volunteers	Phase 1	Completed	BioVersys SAS	16	2021-10-08	2023-01-17
Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Male Subjects BV100, Placebo - Healthy Subjects	Phase 1	Completed	BioVersys SAS	54	2020-11-09	2022-02-08

Interventions

Polymyxin B (2)  ·  Colistin (1)  ·  sultamicillin (1)

Countries

Germany (2)  ·  Austria (1)  ·  Georgia (1)

Top investigators

Denis Strugala, MD (1)

Results publications

PMID 41770249